Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bart Staels

Showing results (151-160 of 638) with videos related to

Pageof 64
Sort By:
The Journal of Biological Chemistry|July 16, 2002
Peroxisome proliferator-activated receptor alpha (PPARalpha ) turnover by the ubiquitin-proteasome system controls the ligand-induced expression level of its target genesChristophe Blanquart, Olivier Barbier, Jean-Charles Fruchart, et al.
Biochemical and Biophysical Research Communications|June 5, 2004
Different ways to regulate the PPARalpha stabilityChristophe Blanquart, Roxane Mansouri, Jean-Charles Fruchart, et al.
Cells|October 1, 2020
Control of Cell Identity by the Nuclear Receptor HNF4 in Organ PathophysiologyVanessa Dubois, Bart Staels, Philippe Lefebvre, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|January 21, 2006
Modulation of hepatic inflammatory risk markers of cardiovascular diseases by PPAR-alpha activators: clinical and experimental evidenceAlberto Zambon, Philippe Gervois, Paolo Pauletto, et al.
The Journal of Biological Chemistry|December 4, 2009
SUMOylation of human peroxisome proliferator-activated receptor alpha inhibits its trans-activity through the recruitment of the nuclear corepressor NCoRBenoit Pourcet, Inés Pineda-Torra, Bruno Derudas, et al.
Current Opinion in Lipidology|March 21, 2019
Bile acid alterations in nonalcoholic fatty liver disease, obesity, insulin resistance and type 2 diabetes: what do the human studies tell?Oscar Chávez-Talavera, Joel Haas, Guillaume Grzych, et al.
Frontiers in Endocrinology|January 29, 2015
O-GlcNAcylation Links ChREBP and FXR to Glucose-SensingFadila Benhamed, Gaelle Filhoulaud, Sandrine Caron, et al.
Molecular Endocrinology (Baltimore, Md.)|February 21, 2009
Rev-erbalpha2 mRNA encodes a stable protein with a potential role in circadian clock regulationJuliette Rambaud, Gérard Triqueneaux, Ingrid Masse, et al.
Biochemical and Biophysical Research Communications|December 15, 2010
Liver X Receptor (LXR) activation negatively regulates visfatin expression in macrophagesThérèse Hèrvée Mayi, Elena Rigamonti, François Pattou, et al.
Biochimica Et Biophysica Acta|April 13, 2007
Safety issues and prospects for future generations of PPAR modulatorsAnne Rubenstrunk, Rémy Hanf, Dean W Hum, et al.
Pageof 64

Showing results (151-160 of 638) with videos related to

Sort By:
Pageof 64
The Journal of Biological Chemistry|July 16, 2002
Peroxisome proliferator-activated receptor alpha (PPARalpha ) turnover by the ubiquitin-proteasome system controls the ligand-induced expression level of its target genesChristophe Blanquart, Olivier Barbier, Jean-Charles Fruchart, et al.
Biochemical and Biophysical Research Communications|June 5, 2004
Different ways to regulate the PPARalpha stabilityChristophe Blanquart, Roxane Mansouri, Jean-Charles Fruchart, et al.
Cells|October 1, 2020
Control of Cell Identity by the Nuclear Receptor HNF4 in Organ PathophysiologyVanessa Dubois, Bart Staels, Philippe Lefebvre, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|January 21, 2006
Modulation of hepatic inflammatory risk markers of cardiovascular diseases by PPAR-alpha activators: clinical and experimental evidenceAlberto Zambon, Philippe Gervois, Paolo Pauletto, et al.
The Journal of Biological Chemistry|December 4, 2009
SUMOylation of human peroxisome proliferator-activated receptor alpha inhibits its trans-activity through the recruitment of the nuclear corepressor NCoRBenoit Pourcet, Inés Pineda-Torra, Bruno Derudas, et al.
Current Opinion in Lipidology|March 21, 2019
Bile acid alterations in nonalcoholic fatty liver disease, obesity, insulin resistance and type 2 diabetes: what do the human studies tell?Oscar Chávez-Talavera, Joel Haas, Guillaume Grzych, et al.
Frontiers in Endocrinology|January 29, 2015
O-GlcNAcylation Links ChREBP and FXR to Glucose-SensingFadila Benhamed, Gaelle Filhoulaud, Sandrine Caron, et al.
Molecular Endocrinology (Baltimore, Md.)|February 21, 2009
Rev-erbalpha2 mRNA encodes a stable protein with a potential role in circadian clock regulationJuliette Rambaud, Gérard Triqueneaux, Ingrid Masse, et al.
Biochemical and Biophysical Research Communications|December 15, 2010
Liver X Receptor (LXR) activation negatively regulates visfatin expression in macrophagesThérèse Hèrvée Mayi, Elena Rigamonti, François Pattou, et al.
Biochimica Et Biophysica Acta|April 13, 2007
Safety issues and prospects for future generations of PPAR modulatorsAnne Rubenstrunk, Rémy Hanf, Dean W Hum, et al.
Pageof 64